1. Homepage
  2. Equities
  3. France
  4. Euronext Paris
  5. ERYTECH Pharma S.A.
  6. News
  7. Summary
    ERYP   FR0011471135

ERYTECH PHARMA S.A.

(ERYP)
  Report
Real-time Euronext Paris  -  11:38 2022-08-12 am EDT
1.350 EUR   +4.65%
08/11European ADRs Move Lower in Thursday Trading
MT
08/09European ADRs Move Higher in Tuesday Trading
MT
08/05European ADRs Move Lower in Friday Trading
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

European ADRs Move Higher in Wednesday Trading

06/15/2022 | 11:08am EDT


© MT Newswires 2022
Stocks mentioned in the article
ChangeLast1st jan.
ADAPTIMMUNE THERAPEUTICS PLC 5.78% 2.38 Delayed Quote.-36.53%
AKARI THERAPEUTICS, PLC -0.99% 1.4851 Delayed Quote.-0.99%
AMARIN CORPORATION PLC 2.48% 1.65 Delayed Quote.-51.04%
AUTOLUS THERAPEUTICS PLC 3.18% 3.57 Delayed Quote.-31.21%
BANCO SANTANDER, S.A. 1.14% 2.6665 Delayed Quote.-9.32%
BARCLAYS PLC 1.55% 171.6 Delayed Quote.-8.24%
ERYTECH PHARMA S.A. 4.65% 1.35 Real-time Quote.-36.32%
GENFIT -4.99% 4.46 Real-time Quote.3.34%
MATERIALISE NV 1.70% 13.76 Delayed Quote.-42.35%
MEREO BIOPHARMA GROUP PLC 17.39% 1.35 Delayed Quote.-15.63%
PRUDENTIAL PLC 0.71% 997 Delayed Quote.-21.77%
SEQUANS COMMUNICATIONS S.A. -1.45% 3.4 Delayed Quote.-28.27%
VEON LTD. 0.83% 0.474 Delayed Quote.-72.28%
VERONA PHARMA PLC 15.17% 13.59 Delayed Quote.102.23%
All news about ERYTECH PHARMA S.A.
08/11European ADRs Move Lower in Thursday Trading
MT
08/09European ADRs Move Higher in Tuesday Trading
MT
08/05European ADRs Move Lower in Friday Trading
MT
08/04European ADRs Move Higher in Thursday Trading
MT
08/03European ADRs Nudge Higher in Wednesday Trading
MT
07/28European ADRs Decline in Thursday Trading
MT
07/22European ADRs Edge Higher in Friday Trading
MT
07/13European ADRs Move Higher in Wednesday Trading
MT
07/11European ADRs Move Lower in Monday Trading
MT
07/07European ADRs Move Higher in Thursday Trading
MT
More news
Analyst Recommendations on ERYTECH PHARMA S.A.
More recommendations
Financials
Sales 2022 9,20 M 9,43 M 9,43 M
Net income 2022 -52,8 M -54,1 M -54,1 M
Net Debt 2022 1,50 M 1,54 M 1,54 M
P/E ratio 2022 -0,61x
Yield 2022 -
Capitalization 41,9 M 42,9 M 42,9 M
EV / Sales 2022 4,71x
EV / Sales 2023 2,53x
Nbr of Employees 181
Free-Float 98,5%
Chart ERYTECH PHARMA S.A.
Duration : Period :
ERYTECH Pharma S.A. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ERYTECH PHARMA S.A.
Short TermMid-TermLong Term
TrendsBullishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus SELL
Number of Analysts 1
Last Close Price 1,35 €
Average target price 3,60 €
Spread / Average Target 167%
EPS Revisions
Managers and Directors
Gil Beyen Chief Executive Officer & Director
Eric Soyer Chief Operating & Financial Officer
Jean-Paul Kress Chairman
Iman El-Hariry Chief Medical Officer
Stewart Craig Chief Technical Officer
Sector and Competitors
1st jan.Capi. (M$)
ERYTECH PHARMA S.A.-36.32%43
GILEAD SCIENCES, INC.-13.29%78 912
VERTEX PHARMACEUTICALS34.12%75 532
REGENERON PHARMACEUTICALS, INC.-0.45%67 214
WUXI APPTEC CO., LTD.-20.10%40 830
BIONTECH SE-37.80%38 968